105 related articles for article (PubMed ID: 29507419)
1. EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Li Z; Takenobu H; Setyawati AN; Akita N; Haruta M; Satoh S; Shinno Y; Chikaraishi K; Mukae K; Akter J; Sugino RP; Nakazawa A; Nakagawara A; Aburatani H; Ohira M; Kamijo T
Oncogene; 2018 May; 37(20):2714-2727. PubMed ID: 29507419
[TBL] [Abstract][Full Text] [Related]
2. Review: Targeting EZH2 in neuroblastoma.
Gao J; Fosbrook C; Gibson J; Underwood TJ; Gray JC; Walters ZS
Cancer Treat Rev; 2023 Sep; 119():102600. PubMed ID: 37467626
[TBL] [Abstract][Full Text] [Related]
3. EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
Bownes LV; Williams AP; Marayati R; Stafman LL; Markert H; Quinn CH; Wadhwani N; Aye JM; Stewart JE; Yoon KJ; Mroczek-Musulman E; Beierle EA
PLoS One; 2021; 16(3):e0246244. PubMed ID: 33690617
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells.
O'Brien E; Tse C; Tracy I; Reddin I; Selfe J; Gibson J; Tapper W; Pengelly RJ; Gao J; Aladowicz E; Petts G; Thway K; Popov S; Kelsey A; Underwood TJ; Shipley J; Walters ZS
Clin Epigenetics; 2023 Oct; 15(1):167. PubMed ID: 37858275
[TBL] [Abstract][Full Text] [Related]
5. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress.
Liao Y; Chen CH; Xiao T; de la Peña Avalos B; Dray EV; Cai C; Gao S; Shah N; Zhang Z; Feit A; Xue P; Liu Z; Yang M; Lee JH; Xu H; Li W; Mei S; Pierre RS; Shu S; Fei T; Duarte M; Zhao J; Bradner JE; Polyak K; Kantoff PW; Long H; Balk SP; Liu XS; Brown M; Xu K
Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35031563
[TBL] [Abstract][Full Text] [Related]
7. Regulatory characterisation of the schizophrenia-associated CACNA1C proximal promoter and the potential role for the transcription factor EZH2 in schizophrenia aetiology.
Billingsley KJ; Manca M; Gianfrancesco O; Collier DA; Sharp H; Bubb VJ; Quinn JP
Schizophr Res; 2018 Sep; 199():168-175. PubMed ID: 29501388
[TBL] [Abstract][Full Text] [Related]
8. CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma.
Zhuo R; Zhang Z; Chen Y; Li G; Du S; Guo X; Yang R; Tao Y; Li X; Fang F; Xie Y; Wu D; Yang Y; Yang C; Yin H; Qian G; Wang H; Yu J; Jia S; Zhu F; Feng C; Wang J; Xu Y; Li Z; Shi L; Wang X; Pan J; Wang J
Cancer Lett; 2024 Jun; 591():216882. PubMed ID: 38636893
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
10. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic Reprogramming.
Tao L; Moreno-Smith M; Ibarra-García-Padilla R; Milazzo G; Drolet NA; Hernandez BE; Oh YS; Patel I; Kim JJ; Zorman B; Patel T; Kamal AHM; Zhao Y; Hicks J; Vasudevan SA; Putluri N; Coarfa C; Sumazin P; Perini G; Parchem RJ; Uribe RA; Barbieri E
Adv Sci (Weinh); 2021 Oct; 8(19):e2005047. PubMed ID: 34365742
[TBL] [Abstract][Full Text] [Related]
11. EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation.
Wang L; Chen C; Song Z; Wang H; Ye M; Wang D; Kang W; Liu H; Qing G
Nat Commun; 2022 Jan; 13(1):12. PubMed ID: 35013218
[TBL] [Abstract][Full Text] [Related]
12. Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas.
Stępniak K; Machnicka MA; Mieczkowski J; Macioszek A; Wojtaś B; Gielniewski B; Poleszak K; Perycz M; Król SK; Guzik R; Dąbrowski MJ; Dramiński M; Jardanowska M; Grabowicz I; Dziedzic A; Kranas H; Sienkiewicz K; Diamanti K; Kotulska K; Grajkowska W; Roszkowski M; Czernicki T; Marchel A; Komorowski J; Kaminska B; Wilczyński B
Nat Commun; 2021 Jun; 12(1):3621. PubMed ID: 34131149
[TBL] [Abstract][Full Text] [Related]
13. Effects of transcription factor
Huang JR; Li Y; Chen P; Wei JX; Yang X; Xu QQ; Chen JB
Ann Surg Treat Res; 2024 May; 106(5):284-295. PubMed ID: 38725807
[TBL] [Abstract][Full Text] [Related]
14. S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.
Sanlav G; Baran B; Kum Özşengezer S; Kizmazoğlu D; Altun Z; Aktaş S; Olgun N
J Pediatr Hematol Oncol; 2024 Jan; 46(1):21-28. PubMed ID: 37943051
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics-transcriptomics joint analysis: unveiling the dysregulated cell death network and developing a diagnostic model for high-grade neuroblastoma.
Zhang W; Zhang M; Sun M; Hu M; Yu M; Sun J; Zhang X; Du B
Front Immunol; 2023; 14():1345734. PubMed ID: 38239355
[TBL] [Abstract][Full Text] [Related]
16. Two bullets in the gun: combining immunotherapy with chemotherapy to defeat neuroblastoma by targeting adrenergic-mesenchymal plasticity.
D'Amico S; Tempora P; Gragera P; Król K; Melaiu O; De Ioris MA; Locatelli F; Fruci D
Front Immunol; 2023; 14():1268645. PubMed ID: 37849756
[TBL] [Abstract][Full Text] [Related]
17. Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.
Ram Kumar RM; Schor NF
Oncotarget; 2018 Apr; 9(31):22184-22193. PubMed ID: 29774131
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma.
Chennakesavalu M; Moore K; Chaves G; Veeravalli S; TerHaar R; Wu T; Lyu R; Chlenski A; He C; Piunti A; Applebaum MA
bioRxiv; 2023 Apr; ():. PubMed ID: 37163024
[TBL] [Abstract][Full Text] [Related]
19. Ntrk1 mutation co-segregating with bipolar disorder and inherited kidney disease in a multiplex family causes defects in neuronal growth and depression-like behavior in mice.
Nakajima K; Miranda A; Craig DW; Shekhtman T; Kmoch S; Bleyer A; Szelinger S; Kato T; Kelsoe JR
Transl Psychiatry; 2020 Nov; 10(1):407. PubMed ID: 33235206
[TBL] [Abstract][Full Text] [Related]
20. Predicting neuroblastoma using developmental signals and a logic-based model.
Kasemeier-Kulesa JC; Schnell S; Woolley T; Spengler JA; Morrison JA; McKinney MC; Pushel I; Wolfe LA; Kulesa PM
Biophys Chem; 2018 Jul; 238():30-38. PubMed ID: 29734136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
